Filtered By:
Condition: Heart Failure
Procedure: Heart Transplant
This page shows you your search results in order of date. This is page number 18.
Order by Relevance | Date
Total 589 results found since Jan 2013.
Sustained Use of the Impella 5.0 Heart Pump Enables Bridge to Clinical Decisions in 34 Patients
Tex Heart Inst J. 2021 Jul 1;48(3):e207260. doi: 10.14503/THIJ-20-7260.ABSTRACTWe studied whether sustained hemodynamic support (>7 d) with the Impella 5.0 heart pump can be used as a bridge to clinical decisions in patients who present with cardiogenic shock, and whether such support can improve their outcomes. We retrospectively reviewed cases of patients who had Impella 5.0 support at our hospital from August 2017 through May 2019. Thirty-four patients (23 with cardiogenic shock and 11 with severely decompensated heart failure) underwent sustained support for a mean duration of 11.7 ± 9.3 days (range, ≤48 d). Of 2...
Source: Texas Heart Institute Journal - August 13, 2021 Category: Cardiology Authors: Daniel W Nelson Sakthi Sundararajan Evan Klein Lyle D Joyce Lucian A Durham David L Joyce Asim A Mohammed Source Type: research
Troubleshooting Left Ventricular Assist Devices: Modern Technology and Its Limitations
AbstractPurpose of reviewAs the incidence of heart failure continues to rise, modern generation left ventricular assist devices (LVADs) have become the primary therapeutic modality used as both bridge to transplant (BTT) and destination therapy (DT) in patients with acute and chronic heart failure. This review aims to highlight the progression of LVAD technology, outline LVAD complications and manifestations, and provide evidence-based therapeutic methods to troubleshoot such adverse events.Recent findingsDespite modern innovation, LVAD adverse events continue to hinder the progress of HF paradigms and are associated with ...
Source: Current Treatment Options in Cardiovascular Medicine - August 2, 2021 Category: Cardiology Source Type: research
Predicting the survivals and favorable neurologic outcomes after targeted temperature management by artificial neural networks
CONCLUSIONS: The ANN-based models achieved good performance to predict the survival and favorable neurologic outcomes after TTM. The models proposed have clinical value to assist in decision-making.PMID:34330620 | DOI:10.1016/j.jfma.2021.07.004
Source: J Formos Med Assoc - July 31, 2021 Category: General Medicine Authors: Wei-Ting Chiu Chen-Chih Chung Chien-Hua Huang Yu-San Chien Chih-Hsin Hsu Cheng-Hsueh Wu Chen-Hsu Wang Hung-Wen Chiu Lung Chan Source Type: research
